Adoptive Transfer - Stand Up To Cancer

Research Teams

Research  >  Research Portfolio  >  Research Teams  >  Adoptive Transfer

Pancreatic Cancer Collective Research Team:
Adoptive Transfer of TGF-β Resistant TIL to Defeat Immunosuppressive PDAC New Therapies Challenge

Grant Term: November 2018–December 2019

Pancreatic cancer cells have a high level of a protein, called TGF-β, that can repress the activity of the immune system in fighting cancers. This research team can isolate tumor-specific killer T cells (called tumor-infiltrating lymphocytes, or TILs) from pancreatic cancer tissue and transfer them back to the patient for maximal impact against the tumor cells. The team is engineering TIL to make the cells resistant to the suppressive effect of TGF-β, potentially enabling the TIL to attack the cancer tissue within the pancreas. 

ABOUT THIS TEAM’S RESEARCH

Reactivation of the immune system’s anticancer function has dramatically improved outcomes for several solid tumor types but has not yet shown similar efficacy for pancreatic cancer. Pancreatic cancer tissue has a high level of transforming growth factor beta (TGF-β). TGF-β effectively counteracts the immune system.

Team researchers have developed methods to isolate the few tumor-specific killer T cells (called tumor-infiltrating lymphocytes, or TILs) from pancreatic cancer tissue and greatly expand their numbers in the laboratory. They can then transfer these TIL cells back to the patient for maximal impact against the tumor cells. They have used this approach very successfully in metastatic melanoma and shown that 42% of treatment-resistant patients derived benefit from the therapy.

The Team is now developing TIL therapy for pancreatic cancer patients, using engineered TILs that are made resistant to the suppressive effect of TGF-β. In the 14-month period of this grant, they are focusing on demonstrating feasibility and potential efficacy of this approach in the laboratory.

This team is part of the Pancreatic Cancer Collective, an initiative of the Lustgarten Foundation for Pancreatic Cancer Research and Stand Up To Cancer.

JOIN OUR COMMUNITY

Sign up to receive emails from Stand Up To Cancer.
   Please leave this field empty
Please validate the captcha
Stand Up to Cancer

Thanks for signing up!
You will hear from us soon.